Ahn Mark J

CIK 00012965434 companiesWORCESTER, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001296543

Recent Transactions

50 trades

Award
ABEONA THERAPEUTICS INC.$ABEO
Stock option (right to buy)
2016-12-13+150,000→ 150,000 total
Exercise/Conversion
ABEONA THERAPEUTICS INC.$ABEO
Common stock
2016-11-08$2.31/sh+150,000→ 493,182 total
Exercise/Conversion
ABEONA THERAPEUTICS INC.$ABEO
Stock option (right to buy)
2016-11-08$2.31/sh+150,000→ 0 total
Award
ABEONA THERAPEUTICS INC.$ABEO
Stock option (right to buy)
2016-02-11+150,000→ 150,000 total
Purchase
ABEONA THERAPEUTICS INC.$ABEO
Common stock
2015-07-31$5.50/sh+18,182→ 343,182 total
Award
ABEONA THERAPEUTICS INC.$ABEO
Common stock
2015-05-11$7.34/sh+300,000→ 325,000 total
Award
ABEONA THERAPEUTICS INC.$ABEO
Common stock
2015-05-11+300,000→ 325,000 total
Award
ABEONA THERAPEUTICS INC.$ABEO
Stock option (right to buy)
2015-05-11$7.34/sh+100,000→ 115,320 total
Award
ABEONA THERAPEUTICS INC.$ABEO
Stock option (right to buy)
2015-05-11+100,000→ 100,000 total
Purchase
ABEONA THERAPEUTICS INC.$ABEO
Common Stock
2015-01-26$4.00/sh+25,000→ 25,000 total
Purchase
ABEONA THERAPEUTICS INC.$ABEO
Common Stock Purchase Warrants
2015-01-26$0.01/sh+25,000→ 25,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2014-06-30$2.60/sh+2,461→ 116,225 total
Other
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2014-06-30$2.60/sh+2,461→ 116,225 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2014-01-27$1.38/sh+100,000→ 263,764 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2014-01-27−121,875→ 423,173 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2014-01-27−200,000→ 200,000 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2014-01-27−100,000→ 0 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2014-01-27−50,000→ 0 total
Sale
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2014-01-27$4.83/sh−796,765→ 113,764 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2014-01-27$1.71/sh+121,875→ 918,529 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2014-01-27$0.72/sh+200,000→ 788,654 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2014-01-27−324,890→ 25,110 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2014-01-27$2.31/sh+50,000→ 163,764 total
Exercise/Conversion
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2014-01-27$1.38/sh+324,890→ 588,654 total
Other
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2013-12-31$1.88/sh+5,656→ 113,764 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (right to buy)
2013-11-26+200,000→ 200,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (right to buy)
2013-11-26+600,000→ 600,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (right to buy)
2013-11-26+600,000→ 600,000 total
Other
SELLAS Life Sciences Group, Inc.$SLS
Common Stock, par value $0.0001
2013-06-30$1.35/sh+7,862→ 108,108 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (right to buy)
2013-01-29+650,000→ 650,000 total
Other
SELLAS Life Sciences Group, Inc.$SLS
Common Stock, par value $0.0001
2012-12-31$1.30/sh+7,668→ 100,246 total
Other
SELLAS Life Sciences Group, Inc.$SLS
Common Stock, par value $0.0001
2012-07-10$0.40/sh+31,289→ 92,578 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (right to buy)
2012-01-12+400,000→ 400,000 total
Other
SELLAS Life Sciences Group, Inc.$SLS
Common Stock, par value $.0001
2011-12-31$0.40/sh+31,289→ 61,289 total
Purchase
SELLAS Life Sciences Group, Inc.$SLS
Common Stock, par value $.0001
2011-12-07$0.66/sh+10,000→ 20,000 total
Purchase
SELLAS Life Sciences Group, Inc.$SLS
Common Stock, par value $.0001
2011-04-20$0.95/sh+10,000→ 10,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2011-03-31+100,000→ 100,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2011-03-31+525,000→ 525,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2011-01-13+50,000→ 50,000 total
Award
IOVANCE BIOTHERAPEUTICS, INC.$IOVA
Stock option (right to buy)
2010-05-26+375,000→ 750,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2010-01-14+50,000→ 50,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option
2009-01-15+50,000→ 150,000 total
Award
Talon Therapeutics, Inc.
Common Stock
2006-06-30+74,887→ 602,631 total
Disposition to Issuer
Talon Therapeutics, Inc.
Stock Options
2006-06-30−329,016→ 0 total
Award
Talon Therapeutics, Inc.
Common Stock
2006-06-30+325,000→ 527,744 total
Award
Talon Therapeutics, Inc.
Common Stock
2006-06-30+85,000→ 287,774 total
Disposition to Issuer
Talon Therapeutics, Inc.
Stock Options (pursuant to anti-dilution provisions)
2006-06-30−79,658→ 0 total
Disposition to Issuer
Talon Therapeutics, Inc.
Stock Options (pursuant to anti-dilution provisions)
2006-06-30−194,568→ 0 total
Award
Talon Therapeutics, Inc.
Stock Options (pursuant to Section 16b-3)
2006-06-30+79,658→ 79,658 total
Award
Talon Therapeutics, Inc.
Stock Options (pursuant to Section 16b-3)
2006-06-30+184,555→ 184,555 total

Companies

Recent Filings

Address

C/O RXI PHARMACEUTICALS CORPORATION 60 PRESCOTT STREET

WORCESTER, MA, 01605

View on SEC.gov